Sources
Where the information on this site comes from. Each page also lists the sources for each section.
- FDA and Kratom. U.S. Food and Drug Administration. Accessed 2026-10-21.
- FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers. U.S. Food and Drug Administration, 2025-07-29. Accessed 2026-10-21.
- Schedules of Controlled Substances: Temporary Placement of 7-Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I. Drug Enforcement Administration, Federal Register, 2026-10-14. Accessed 2026-10-21.
- Opiate and opioid withdrawal. MedlinePlus, National Library of Medicine, 2026-05-15. Accessed 2026-10-21.
- A Case of 7-Hydroxymitragynine Use Requiring Inpatient Medically Managed Withdrawal. Journal of Addiction Medicine (Wightman RS, Hu D), 2026. Accessed 2026-10-21.
- Lifesaving Naloxone. Centers for Disease Control and Prevention, 2025-06-11. Accessed 2026-10-21.
- Mitragynine and 7-hydroxymitragynine: Bidirectional effects on breathing in rats. Journal of Pharmacology and Experimental Therapeutics (Zuarth Gonzalez JD et al.), 2025. Accessed 2026-10-21.
- 5 Things to Know About Naloxone. Centers for Disease Control and Prevention, 2024-05-02. Accessed 2026-10-21.
- How do medications to treat opioid use disorder work?. National Institute on Drug Abuse. Accessed 2026-10-23.
- Medications for Opioid Use Disorder. National Institute on Drug Abuse. Accessed 2026-10-23.
- Buprenorphine Sublingual and Buccal (opioid dependence). MedlinePlus, National Library of Medicine. Accessed 2026-10-23.
- TIP 63: Medications for Opioid Use Disorder. Substance Abuse and Mental Health Services Administration, 2024-10-11. Accessed 2026-10-23.
- FindTreatment.gov. Substance Abuse and Mental Health Services Administration. Accessed 2026-10-21.
- Opioid Treatment Program Directory. Substance Abuse and Mental Health Services Administration, 2026-01-14. Accessed 2026-10-21.
- What Is a Health Center?. Health Resources and Services Administration. Accessed 2026-10-23.
- Expansion of Buprenorphine Treatment via Telemedicine Encounter. DEA and HHS, Federal Register, 2025-01-17. Accessed 2026-10-21.
- Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for VA Patients (effective date delay). DEA and HHS, Federal Register, 2025-03-24. Accessed 2026-10-21.
- Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. DEA and HHS, Federal Register, 2025-12-31. Accessed 2026-10-21.
- Preventing an Opioid Overdose: Know the Signs. Save a Life.. Centers for Disease Control and Prevention. Accessed 2026-10-23.
- If You Think Someone Is Overdosing. Centers for Disease Control and Prevention. Accessed 2026-10-23.
- Information about Naloxone and Nalmefene. U.S. Food and Drug Administration, 2024-08-08. Accessed 2026-10-21.
- Naloxone Nasal Spray. MedlinePlus, National Library of Medicine, 2026-09-15. Accessed 2026-10-21.
- Benzodiazepines and Opioids. National Institute on Drug Abuse, 2022-11-07. Accessed 2026-10-21.
- SAMHSA's National Helpline. Substance Abuse and Mental Health Services Administration, 2023-06-09. Accessed 2026-10-21.
- Find a Health Center. Health Resources and Services Administration. Accessed 2026-10-21.
- Bicycle Health. Bicycle Health. Accessed 2026-10-21.
- Boulder Care. Boulder Care. Accessed 2026-10-21.
- Groups Recover Together. Groups. Accessed 2026-10-21.
- Ophelia. Ophelia. Accessed 2026-10-21.
- QuickMD. QuickMD. Accessed 2026-10-21.
- Workit Health. Workit Health. Accessed 2026-10-21.
- Join Our Daily Kratom Addiction Recovery Meetings Support Community. Quitting Kratom Support. Accessed 2026-10-21.
- Meetings. Quitting Kratom Support (Kratom Quitters). Accessed 2026-10-22.
- TripSit. TripSit. Accessed 2026-10-21.
- DanceSafe. DanceSafe. Accessed 2026-10-21.
Spot an error? Email support@exitseven.app
Are you a clinician? Help review.